pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Lupin Ltd

updated 2mo ago

Lupinus, commonly known as lupin, lupine, or regionally bluebonnet, is a genus of plants in the legume family Fabaceae. The genus includes over 199 species, with centres of diversity in North and South America. Smaller centres occur in North Africa and the Mediterranean. They are widely cultivated both as a food source and as ornamental plants, but are invasive to some areas. For instance, lupine has become an ecological problem in Iceland since the beginning of the 21st century.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval116 co-mentions · 58 sources
  • tagSmall Molecule57 co-mentions · 57 sources
  • drugALDACTAZIDE48 co-mentions · 24 sources
  • drugARBLI14 co-mentions · 14 sources
  • drugLOSARTAN POTASSIUM14 co-mentions · 14 sources
  • drugLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE14 co-mentions · 14 sources
  • drugTRAMADOL HYDROCHLORIDE13 co-mentions · 13 sources
  • drugtramadol hydrochloride ER13 co-mentions · 13 sources
pipeline
35
marketed
27
phase 3
1
catalysts ytd
10
approvals ytd
9
recalls ytd
0

Pipeline(35)

view full pipeline →
pipeline depth35 products
Phase 3: 1Marketed: 27Unknown: 7
1Phase 327Marketed7Unknown
Marketed
(amlodipine besylate + benazepril hydrochloride)
Hypertension
Marketed
(emtricitabine + tenofovir alafenamide fumarate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Marketed
(ethinylestradiol + norgestrel)
Female Contraception
Marketed
(famotidine + ibuprofen)
Duodenal Ulcer
Marketed
(ketorolac tromethamine + phenylephrine hydrochloride)
Ocular Pain (Eye Pain)
Marketed
ARMLUPEG
Marketed
Antara
Hypercholesterolemia
Marketed
CEFIXIME
Uncomplicated Cervical And Urethral Gonorrhea
Marketed
DAPAGLIFLOZIN
Type 2 Diabetes
Marketed
GLYCEROL PHENYLBUTYRATE
Urea Cycle Disorders
Marketed
Pennsaid
Osteoarthritis Pain
Marketed
Suprax
Urinary Tract Infections

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase3The Efficacy and Safety of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2recruitingn=176
  • phase3Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMDcompletedn=600
  • phase3An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Once Daily Mexiletine PR in Patients With Myotonic Dystrophy Type 1 and Type 2 Who Have Completed MEX-DM-302 Study.enrolling by invitationn=176
  • phase3An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IRrecruitingn=24
  • —Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disordersrecruitingn=10
  • N/AOpen-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.active not recruitingn=14
  • —An Observational Study in Adult Patients With Non-dystrophic Myotonic Disordersactive not recruitingn=53
  • phase3Open Label Study in Adolescents and Children With Myotonic Disorderscompletedn=12
more trials →
🐶 Hiring Signal
No open roles indexed yet — view Lupin Ltd jobs →

News

no news has mentioned this company yet
identifiers
source
globaldata
top tags
Infectious Disease6Cardiology4Pulmonology4Hypertension3Immunology2
mentioned in
0news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?